Occuity has secured a major £1.5 million Innovate UK grant after being selected as one of just eight projects funded from 347 applications to the Biomedical Catalyst 2025 programme.

It was widely reported yesterday, that the commonly used HbA1c test for diagnosing and monitoring Type 2 diabetes, has been found to potenti